Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer
This study has been terminated.
(low patient accrual)
Sponsor:
Leo W. Jenkins Cancer Center
Collaborator:
Genentech
Information provided by:
Leo W. Jenkins Cancer Center
ClinicalTrials.gov Identifier:
NCT00600210
First received: January 11, 2008
Last updated: April 27, 2011
Last verified: April 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | April 2011 |
| Primary Completion Date: | April 2011 (Final data collection date for primary outcome measure) |